Clinical Trials Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8740-8748
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8740
Table 1 Comparison of baseline characteristics of insomnia patients in the treatment group and control group
Characteristic
Treatment, n = 40
Control, n = 40
Age in yr, mean ± SD52.4 ± 11.551.3 ± 10.2
Male sex, n/total n (%)13/40 (32.5)15/40 (37.5)
Married, n/total n (%)37/40 (92.5)38/40 (95)
University graduate, n/total n (%)32/40 (80)34/40 (85)
Table 2 Patient group Pittsburgh Sleep Quality Index score comparison before intervention
Group
Sleep quality
Sleep latency
Sleep duration
Sleep efficiency
Sleep disturbance
Hypnotic medication
Daytime dysfunction
Treatment group, n = 402.83 ± 0.392.93 ± 0.422.93 ± 0.272.80 ± 0.412.70 ± 0.461.08 ± 0.832.53 ± 0.64
Control group, n = 402.70 ± 0.462.90 ± 0.302.93 ± 0.272.75 ± 0.442.73 ± 0.451.23 ± 1.002.63 ± 0.54
t-1.311-0.3910.000-0.5300.2440.7310.755
P value0.1940.6971.0000.5980.8080.4670.452
Table 3 Patient group Pittsburgh Sleep Quality Index score comparison 1 wk after intervention
Group
Sleep quality
Sleep latency
Sleep duration
Sleep efficiency
Sleep disturbance
Daytime dysfunction
Treatment group, n = 400.98 ± 0.362.55 ± 0.501.60 ± 0.631.75 ± 0.541.70 ± 0.561.63 ± 0.54
Control group, n = 401.05 ± 0.502.68 ± 0.471.60 ± 0.591.83 ± 0.451.70 ± 0.521.70 ± 0.46
t0.7690.3910.0000.6750.0000.666
P value0.4450.6971.0000.5021.0000.507
Table 4 Patient group Pittsburgh Sleep Quality Index score comparison 1 mo after intervention
Group
Sleep quality
Sleep latency
Sleep duration
Sleep efficiency
Sleep disturbance
Hypnotic medication use
Daytime dysfunction
Treatment group, n = 400.95 ± 0.322.20 ± 0.411.48 ± 0.642.25 ± 0.591.50 ± 0.562.70 ± 0.791.55 ± 0.60
Control group, n = 401.28 ± 0.512.73 ± 0.452.40 ± 0.631.68 ± 0.472.39 ± 0.492.60 ± 0.842.38 ± 0.54
t3.4465.4696.502-4.8127.475-0.5486.481
P value< 0.001< 0.001< 0.001< 0.001< 0.001< 0.001< 0.001
Table 5 Patient group Pittsburgh Sleep Quality Index score comparison 3 mo after intervention
Group
Sleep quality
Sleep latency
Sleep duration
Sleep efficiency
Sleep disturbance
Hypnotic medication use
Daytime dysfunction
Treatment group, n = 400.98 ± 0.481.98 ± 0.531.53 ± 0.602.35 ± 0.581.68 ± 0.530.53 ± 0.641.43 ± 0.50
Control group, n = 401.60 ± 0.632.80 ± 0.412.70 ± 0.561.63 ± 0.492.35 ± 0.530.93 ± 0.802.48 ± 0.51
t4.9807.8179.037-6.0405.7002.4759.332
P value< 0.001< 0.001< 0.001< 0.001< 0.001< 0.001< 0.001
Table 6 Patient group Generalized Anxiety Disorder 7-item scale total score comparison before and after interventions
Group
Before intervention
After intervention
1 wk
1 mo
3 mo
Treatment group, n = 4012.20 ± 4.075.60 ± 1.873.38 ± 1.682.75 ± 1.50
Control group, n = 4011.18 ± 1.974.98 ± 1.756.05 ± 1.807.15 ± 2.28
t-1.431-1.5476.88810.195
P value0.1560.126< 0.001< 0.001
Table 7 Patient group Insomnia Severity Index score comparison before and after interventions
Group
Before intervention
After intervention
1 wk
1 mo
3 mo
Treatment group, n = 4022.13 ± 3.3010.63 ± 1.965.75 ± 1.288.68 ± 2.26
Control group, n = 4021.38 ± 2.8811.95 ± 1.057.40 ± 2.453.38 ± 1.76
t-1.083-0.9743.781-11.699
P value0.2820.333< 0.001< 0.001